$SRPT Headlines Small health companies see large gains

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2014 at 9:49 AM

$SRPT Headlines

Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Tiny biotechs Sarepta and Revance make big waves on a strong day for the sector 3:35 p.m. April 22, 2014 - Russ Britt
Stocks rise; S&P 500 in longest win streak in 6 mths 4:49 p.m. April 21, 2014 - Anora Mahmudova
Netflix recovers ahead of results; Newmont tops S&P 500 3:32 p.m. April 21, 2014 - Sue Chang
Biotech surges on hopes FDA will fast-track muscular dystrophy drug 12:54 p.m. April 21, 2014 - Russ Britt
U.S. stock futures flip-flop; Hasbro jumps 4% 9:05 a.m. April 21, 2014 - Barbara Kollmeyer
Sarepta to reapply for FDA approval of MD drug 8:34 a.m. April 21, 2014 - MarketWatch.com
Sarepta surges 74% on plans for drug application 7:40 a.m. April 21, 2014 - Saumya Vaishampayan
Sarepta up 75% on plans for drug application 7:33 a.m. April 21, 2014 - Saumya Vaishampayan
7 gut checks before the stock market's opening bell 8:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 9:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 7:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 1:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 12:10 p.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 12:15 p.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 3:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 5:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 11:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 9:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 9:49 a.m. March 14, 2013 - The Trading Deck

Who Is Working on Ebola? 9:59 a.m. Sept. 19, 2014 - Barrons.com
Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment 3:08 p.m. Sept. 18, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Sarepta Therapeutics' (SRPT) CEO Chris Garabedian at Morgan Stanley Healthcare Conference (Transcript) 8:10 p.m. Sept. 10, 2014 - Seeking Alpha
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
4 Companies To Look At After WHO Ebola Consultation In Geneva 11:51 a.m. Sept. 8, 2014 - Seeking Alpha
Ebola cases accelerating 7:10 a.m. Aug. 28, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade 3:12 p.m. Aug. 27, 2014 - Seeking Alpha
Sarepta partners with diagnostic firm to develop DMD tests 10:37 a.m. Aug. 21, 2014 - Seeking Alpha
Cash In on Taser's Gains With Moves in Options 10:35 a.m. Aug. 20, 2014 - Barrons.com
Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog 2:49 p.m. Aug. 12, 2014 - Zacks.com
Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars 1:04 p.m. Aug. 8, 2014 - Investors Business Daily
Today's Market: News Moving These Names 11:09 a.m. Aug. 8, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT) 11:09 a.m. Aug. 8, 2014 - TheStreet.com
Sarepta's (SRPT) CEO Chris Garabedian on Q2 2014 Results - Earnings Call Transcript 5:45 p.m. Aug. 7, 2014 - Seeking Alpha
Sarepta Therapeutics (SRPT) Q2 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
10-Q: SAREPTA THERAPEUTICS, INC. 6:51 a.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sarepta Should Shut Up About Ebola, Focus on Job No. 1 12:07 p.m. Aug. 6, 2014 - TheStreet.com
'Fast Money' Recap: Geopolitical Pressures Weigh on Stocks 5:00 a.m. Aug. 6, 2014 - TheStreet.com

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 8:01 a.m. Aug. 28, 2014 - BusinessWire - BZX
Critical Alerts For Lowes, FuelCell Energy, Sarepta Therapeutics, Nuance Communications and Herbalife Released By InvestorsObserver 9:31 a.m. Aug. 20, 2014 - PR Newswire - PRF
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Sarepta Therapeutics Announces Second Quarter 2014 Financial Results and Recent Corporate Developments 7:37 a.m. Aug. 7, 2014 - BusinessWire - BZX
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Sarepta Therapeutics Announces Appointment of John Hodgman As Interim Chairman 5:11 p.m. July 31, 2014 - BusinessWire - BZX
Sarepta Therapeutics to Present Company Overview at Canaccord Annual Growth Conference 11:15 a.m. July 31, 2014 - BusinessWire - BZX
Sarepta Therapeutics to Announce Second Quarter 2014 Financial Results and Corporate Update on August 7, 2014 10:54 a.m. July 31, 2014 - BusinessWire - BZX
Critical Alerts For Johnson Controls, Sarepta Therapeutics, China Life Insurance, Finisar, and Petroleo Brasileiro Released By InvestorsObserver 9:31 a.m. July 31, 2014 - PR Newswire - PRF
Flexion Therapeutics Announces Board Changes 8:01 a.m. July 24, 2014 - GlobeNewswire
Critical Alerts For General Electric, Sarepta Therapeutics, iRobot, Goldman Sachs, and Baidu Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Sarepta Therapeutics Reports Long-Term Outcomes Through 144 Weeks from Phase IIb Study of Eteplirsen in Duchenne Muscular Dystrophy 8:31 a.m. July 10, 2014 - BusinessWire - BZX
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For RF Micro Devices, Sarepta Therapeutics, Smith & Wesson, SINA, and Canadian Solar Released By InvestorsObserver 9:31 a.m. June 20, 2014 - PR Newswire - PRF
Sarepta Therapeutics to Present Company Overview at the JMP Securities Healthcare Conference on June 24 4:30 p.m. June 18, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Sarepta Therapeutics Inc. Regarding Possible Breaches of Fiduciary Duty 12:59 p.m. June 9, 2014 - PR Newswire - PRF
Sarepta Therapeutics Opens New Global Headquarters in Cambridge, Mass. 9:42 a.m. June 2, 2014 - BusinessWire - BZX
Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene 5:10 a.m. May 28, 2014 - PR Newswire - PRF
Critical Alerts For Celldex Therapeutics, Best Buy, Weibo, Sarepta Therapeutics, and Dollar Tree Released By InvestorsObserver 9:31 a.m. May 23, 2014 - PR Newswire - PRF
Top Gainers Technical Coverage -- Research on NeuStar, Signet Jewelers, Galena Biopharma, and Sarepta Therapeutics 9:29 a.m. May 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Law Firm Gains Strength with Strategic New Hires

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Are FULC, WEAV, TECH Shareholders Getting a Raw Deal?

Pocketing Insider Gains Amidst Shareholder Concerns Let me tell you, it smells like another day in the financial jungle where insiders might be feasting while the regular Joe shareholders are left nibbling on crumbs. Fulcrum Therapeutics, Weave Communications, and Bio-Techne are in the crosshairs for deals that may favor those on the inside track over you and me, the...

Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Job Market Shifts: Adaptation vs. Fairness Dilemma

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Aflac's $200M Milestone in Cancer Charity Support

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Monib Zirvi's Dermatology Excellence Honored in 2026

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

South Florida Donor Network Honors 52 Heroic Donors

A Heartfelt Tribute to Lifesavers You ever been to a gathering that reminds you how deeply human connections run? That's what happened at The Diplomat Beach Resort in Hollywood. South Florida Donor Network (SFDN) pulled together a ceremony honoring 52 donor heroes whose legacies beat strong through the recipients living thanks to their gifts. An Event Worth Attending...